PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer
Technological breakthroughs, shifting consumer behavior, and evolving health risks are reshaping the future of veterinary care worldwide
Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) — The global veterinary diagnostics market, valued at US$3.42 billion in 2024, stood at US$3.68 billion in 2025 and is projected to advance at a resilient CAGR of 7.8% from 2025 to 2030, culminating in a forecasted valuation of US$5.36 billion by the end of the period. The surge is fueled by the accelerating adoption of advanced diagnostic tools, the increasing prevalence of zoonotic and companion animal diseases, and the integration of artificial intelligence (AI) into diagnostic workflows.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=26017452
What Is Driving Growth?
The market’s expansion is powered by several critical factors:
Get the latest news
delivered to your inbox Sign up for The Manila Times newsletters By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.
Rising pet ownership and spending on animal healthcare: Companion animals have become integral members of households, particularly in developed and urbanized regions, fueling demand for preventive screenings and sophisticated diagnostics.Technological advancements: Rapid developments in point-of-care devices, PCR and LAMP molecular diagnostics, and AI-driven analysis tools are enhancing diagnostic precision, speed, and accessibility.Infectious disease prevalence: Diagnostics for parvovirus, feline leukemia, avian influenza, and foot-and-mouth disease are in high demand to prevent outbreaks and ensure food chain stability.Shift toward early disease detection: Growing awareness of diabetes, kidney disorders, and cancer in pets has created strong demand for early, reliable diagnostics.What Challenges Remain?
Despite growth, the market faces hurdles:
Advertisement
High cost of advanced tests: Molecular assays, MRIs, and genetic testing remain financially challenging for many owners and service providers.Shortage of skilled professionals: A global gap in trained veterinary specialists limits adoption of advanced diagnostic modalities, particularly in developing regions.Where Are the Opportunities?
Strategic opportunities lie in AI-powered diagnostics, telemedicine, and digital health integration. Smart collars, wearable trackers, and cloud-enabled diagnostic platforms are enabling faster interventions and remote care. The rise of veterinary telehealth services, especially in underserved regions, is expected to accelerate adoption.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=26017452
Who Are the Key Players?
Advertisement
Industry leaders driving innovation include IDEXX Laboratories (US), Zoetis Services LLC (US), Thermo Fisher Scientific (US), Antech Diagnostics (US), bioMérieux (France), Neogen Corporation (US), Bio-Rad Laboratories (US), Virbac (France), FUJIFILM Holdings (Japan), and Mindray Animal Medical (China). These companies are advancing their portfolios through R&D investments, product launches, and strategic partnerships.
Recent industry highlights include:
bioMérieux (France) – Launched VETFIRE PCR kit for equine infectious respiratory diseases (June 2025).Antech Diagnostics (US) – Introduced trūRapid FOUR, an in-house canine vector-borne disease screening test (March 2025).Neogen Corporation (US) – Released Igenity BCHF test to detect genetic predisposition to bovine congestive heart failure (January 2025).Zoetis (US) – Rolled out Vetscan OptiCell, an AI-powered cartridge-based CBC analyzer for clinics (December 2024).IDEXX Laboratories (US) – Launched inVue Dx Cellular Analyzer for slide-free cytology (January 2024).Regional Outlook: Where Is Growth Happening?
Advertisement North America holds the largest market share in 2024, supported by high pet insurance penetration, advanced clinical practices, and the presence of leading manufacturers.Asia Pacific is forecast to grow at the highest CAGR, driven by rising pet adoption, expanding veterinary infrastructure, and increasing awareness of zoonotic disease control.Industry Relevance: Why Now?
The convergence of rising zoonotic threats, heightened pet healthcare awareness, and AI-driven innovation underscores the urgency of investment in veterinary diagnostics. For global decision-makers in healthcare, biotechnology, and insurance, this market represents not only a growing revenue stream but also a critical component of public health resilience and food security.
About the Pulse Oximeters Market Report
This comprehensive market analysis covers global revenue forecasts, competitive benchmarking, and emerging opportunities across regions, products, and end users. The report is designed for executives, investors, and
policymakers seeking strategic insights into one of the fastest-growing segments of the medical devices industry.
Advertisement
For more information, Inquire Now!
Discover Connected Healthcare Market Opportunities:
Veterinary Reference Laboratory Market
Veterinary Infectious Disease Diagnostics Market
Advertisement
Companion Animal Diagnostics Market
Animal Genetics Market
Animal Wound Care Market
Get access to the latest updates on Top Companies in Veterinary Diagnostics and Veterinary Diagnostics Market Size
Advertisement
CONTACT: About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit http://www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445,
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: http://www.marketsandmarkets.com
